Gilardi, E.; Pomero, F.; Ravera, E.; Piccioni, A.; Santoro, M.C.; Bonadia, N.; Carnicelli, A.; Di Maurizio, L.; Sabia, L.; Longhitano, Y.;
et al. Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care. J. Clin. Med. 2022, 11, 5527.
https://doi.org/10.3390/jcm11195527
AMA Style
Gilardi E, Pomero F, Ravera E, Piccioni A, Santoro MC, Bonadia N, Carnicelli A, Di Maurizio L, Sabia L, Longhitano Y,
et al. Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care. Journal of Clinical Medicine. 2022; 11(19):5527.
https://doi.org/10.3390/jcm11195527
Chicago/Turabian Style
Gilardi, Emanuele, Fulvio Pomero, Enrico Ravera, Andrea Piccioni, Michele Cosimo Santoro, Nicola Bonadia, Annamaria Carnicelli, Luca Di Maurizio, Luca Sabia, Yaroslava Longhitano,
and et al. 2022. "Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care" Journal of Clinical Medicine 11, no. 19: 5527.
https://doi.org/10.3390/jcm11195527
APA Style
Gilardi, E., Pomero, F., Ravera, E., Piccioni, A., Santoro, M. C., Bonadia, N., Carnicelli, A., Di Maurizio, L., Sabia, L., Longhitano, Y., Saviano, A., Ojetti, V., Savioli, G., Zanza, C., & Franceschi, F.
(2022). Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care. Journal of Clinical Medicine, 11(19), 5527.
https://doi.org/10.3390/jcm11195527
